Skip to main content
. Author manuscript; available in PMC: 2014 Jun 30.
Published in final edited form as: Am Heart J. 2013 Feb 20;165(4):622–629. doi: 10.1016/j.ahj.2012.12.019

Figure 1.

Figure 1

Unadjusted use of antithrombotic therapies. Aspirin only included aspirin/dipyridamole, (n = 14, 0.14%). Any ADP inhibitor included clopidogrel or prasugrel, with or without aspirin, but no oral anticoagulant. Systemic anticoagulation included warfarin or dabigatran (with any antiplatelet). *P < .05 for the comparison between rate control and rhythm control groups. ADP: adenosine diphosphate.